VEGFR2 Antibody

Référence MBS8583524-0,1mL-FITC

Conditionnement : 0.1mL(FITC)

Marque : MyBiosource

Contactez votre distributeur local :


Téléphone : +1 850 650 7790

VEGFR2 Antibody – Rabbit Polyclonal

For Research Use Only. Not for use in diagnostic procedures. Catalog #: MBS8583524

MBS8583524 is an antibody targeting VEGFR2. Also known as VEGFR2 Antibody. Reactive in Human, Monkey. Host: Rabbit. Rabbit polyclonal antibody to VEGFR2 More details

Product Overview

Online Datasheet in PDF
Product Name
VEGFR2, Polyclonal Antibody
Full Product Name
VEGFR2 Antibody
Product Gene Name
anti-VEGFR2 antibody
Product Synonym Gene Name
KDR
Product Synonym Names
FLK1; VEGFR2; Vascular endothelial growth factor receptor 2; VEGFR-2; Fetal liver kinase 1; FLK-1; Kinase insert domain receptor; KDR; Protein-tyrosine kinase receptor flk-1; CD309
Clonality
Polyclonal
Isotype
IgG
Host
Rabbit
Species Reactivity
Human, Monkey
Form/Format
Liquid in 0.42% Potassium phosphate, 0.87% Sodium chloride, pH7.3, 30% glycerol, and 0.01% sodium azide.
Purity/Purification
The antibody was purified by immunogen affinity chromatography.
Specificity
Recognizes endogenous levels of VEGFR2 protein.
Preparation and Storage
Shipped at 4 degree C. Upon delivery aliquot and store at -20 degree C for one year. Avoid freeze/thaw cycles.
Molecular Weight
151,527 Da
Chromosome Location
Chromosome: 4; NC_000004.11 (55944426..55991762, complement). Location: 4q11-q12
OMIM
191306
3D Structure
ModBase 3D Structure for P35968
Immunogen
KLH-conjugated synthetic peptide encompassing a sequence within the center region of human VEGFR2. The exact sequence is proprietary.

Product Categories/Family for anti-VEGFR2 antibody

Primary Antibody
ISO Certification
Manufactured in an ISO 9001:2015 Certified Laboratory.
Applications Tested/Suitable for anti-VEGFR2 antibody
Western Blot (WB)
Application Notes for anti-VEGFR2 antibody
WB: 1:500-1:1000

Other Notes

Small volumes of anti-VEGFR2 antibody vial(s) may occasionally become entrapped in the seal of the product vial during shipment and storage. If necessary, briefly centrifuge the vial on a tabletop centrifuge to dislodge any liquid in the container`s cap. Certain products may require to ship with dry ice and additional dry ice fee may apply.

Additional Details

NCBI/Uniprot data below describe general gene information for VEGFR2. It may not necessarily be applicable to this product.

NCBI GI #
NCBI GeneID
NCBI Accession #
UniProt Primary Accession #
UniProt Secondary Accession #
UniProt Related Accession #
GenBank Nucleotide #
NCBI Official Full Name
vascular endothelial growth factor receptor 2
NCBI Official Synonym Full Names
kinase insert domain receptor (a type III receptor tyrosine kinase)
NCBI Official Symbol
KDR
NCBI Official Synonym Symbols
FLK1; CD309; VEGFR; VEGFR2
UniProt Protein Name
Vascular endothelial growth factor receptor 2
UniProt Synonym Protein Names
Fetal liver kinase 1; FLK-1; Kinase insert domain receptor; KDR; Protein-tyrosine kinase receptor flk-1
UniProt Gene Name
KDR
UniProt Synonym Gene Names
FLK1; VEGFR2; VEGFR-2; FLK-1; KDR
UniProt Entry Name
VGFR2_HUMAN
NCBI Protein Information
vascular endothelial growth factor receptor 2; soluble VEGFR2; fetal liver kinase 1; fetal liver kinase-1; protein-tyrosine kinase receptor Flk-1; tyrosine kinase growth factor receptor

NCBI Summary for VEGFR2

Vascular endothelial growth factor (VEGF) is a major growth factor for endothelial cells. This gene encodes one of the two receptors of the VEGF. This receptor, known as kinase insert domain receptor, is a type III receptor tyrosine kinase. It functions as the main mediator of VEGF-induced endothelial proliferation, survival, migration, tubular morphogenesis and sprouting. The signalling and trafficking of this receptor are regulated by multiple factors, including Rab GTPase, P2Y purine nucleotide receptor, integrin alphaVbeta3, T-cell protein tyrosine phosphatase, etc.. Mutations of this gene are implicated in infantile capillary hemangiomas. [provided by RefSeq, May 2009]
Show more

UniProt Comments for VEGFR2

VEGFR2: a receptor tyrosine kinase of the VEGFR family. High affinity receptor for VEGF and VEGF-C. Ligand binding induces autophosphorylation and activation. Activated receptor recruits proteins including Shc, GRB2, PI3K, Nck, SHP-1 and SHP-2. Plays a key role in vascular development and regulation of vascular permeability.

Protein type: Membrane protein, integral; Kinase, protein; Protein kinase, tyrosine (receptor); Protein kinase, TK; EC 2.7.10.1; TK group; VEGFR family

Chromosomal Location of Human Ortholog: 4q11-q12

Cellular Component: Golgi apparatus; integral to plasma membrane; endoplasmic reticulum; early endosome; cytoplasmic membrane-bound vesicle; extracellular region; plasma membrane; cell junction; nucleus; endosome; external side of plasma membrane; lipid raft

Molecular Function: integrin binding; vascular endothelial growth factor receptor activity; protein binding; growth factor binding; protein-tyrosine kinase activity; receptor signaling protein tyrosine kinase activity; transmembrane receptor protein tyrosine kinase activity; Hsp90 protein binding; ATP binding

Biological Process: extracellular matrix organization and biogenesis; positive regulation of positive chemotaxis; peptidyl-tyrosine phosphorylation; viral reproduction; protein amino acid autophosphorylation; cell maturation; calcium ion homeostasis; regulation of cell shape; positive regulation of focal adhesion formation; ovarian follicle development; positive regulation of MAPKKK cascade; positive regulation of cell proliferation; positive regulation of mesenchymal cell proliferation; angiogenesis; vasculogenesis; endothelial cell differentiation; cell fate commitment; embryonic hemopoiesis; positive regulation of phosphoinositide 3-kinase cascade; positive regulation of angiogenesis; cell migration during sprouting angiogenesis; branching morphogenesis of a tube; positive regulation of endothelial cell proliferation; positive regulation of protein amino acid phosphorylation; vascular endothelial growth factor receptor signaling pathway; lymph vessel development; alveolus development; surfactant homeostasis; transmembrane receptor protein tyrosine kinase signaling pathway; negative regulation of apoptosis; positive regulation of nitric-oxide synthase biosynthetic process; positive regulation of cell migration

Disease: Hemangioma, Capillary Infantile
Show more

Precautions

All of MyBioSource's Products are for scientific laboratory research purposes and are not for diagnostic, therapeutics, prophylactic or in vivo use. Through your purchase, you expressly represent and warrant to MyBioSource that you will properly test and use any Products purchased from MyBioSource in accordance with industry standards. MyBioSource and its authorized distributors reserve the right to refuse to process any order where we reasonably believe that the intended use will fall outside of our acceptable guidelines.

Disclaimer

While every efforts were made to ensure the accuracy of the information provided in this datasheet, MyBioSource will not be liable for any omissions or errors contained herein. MyBioSource reserves the right to make changes to this datasheet at any time without prior notice.

It is the responsibility of the customer to report product performance issues to MyBioSource within 30 days of receipt of the product. Please visit our Terms & Conditions page for more information.

Product Note

Select online data sheet information is drawn from bioinformatics databases, occasionally resulting in ambiguous or non-relevant product information. It is the responsibility of the customer to review, verify, and evaluate the information to make sure it matches their requirements before purchasing the kit. Our ELISA Kit assays are dynamic research tools and sometimes they may be updated and improved. If the format of this assay is important to you then please request the current manual or contact our technical support team with a presales inquiry before placing an order. We will confirm the current details of the assay. We cannot guarantee the sample manual posted online is the most current manual, it is intended to serve as an example only. Please refer to the instructions For Use provided with the assay kit for precise details.

Product PubMed Publications

Products associated with anti-VEGFR2 antibody

Pathways associated with anti-VEGFR2 antibody

 Products by Pathway  Pathway Diagram
 Angiogenesis Pathway antibodies  Angiogenesis Pathway Diagram
 Cardiac Progenitor Differentiation Pathway antibodies  Cardiac Progenitor Differentiation Pathway Diagram
 Cytokine-cytokine Receptor Interaction Pathway antibodies  Cytokine-cytokine Receptor Interaction Pathway Diagram
 Cytokine-cytokine Receptor Interaction Pathway antibodies  Cytokine-cytokine Receptor Interaction Pathway Diagram
 Endocytosis Pathway antibodies  Endocytosis Pathway Diagram
 Endocytosis Pathway antibodies  Endocytosis Pathway Diagram
 Focal Adhesion Pathway antibodies  Focal Adhesion Pathway Diagram
 Focal Adhesion Pathway antibodies  Focal Adhesion Pathway Diagram
 Focal Adhesion Pathway antibodies  Focal Adhesion Pathway Diagram
 HIF-2-alpha Transcription Factor Network Pathway antibodies  HIF-2-alpha Transcription Factor Network Pathway Diagram

Diseases associated with anti-VEGFR2 antibody

 Disease Name  Pubmed Publications
 Neoplasms Antibodies  >623 publications with VEGFR2 and Neoplasms
 Neovascularization, Pathologic Antibodies  >369 publications with VEGFR2 and Neovascularization, Pathologic
 Heart Diseases Antibodies  >138 publications with VEGFR2 and Heart Diseases
 Myocardial Ischemia Antibodies  >127 publications with VEGFR2 and Myocardial Ischemia
 Adenocarcinoma Antibodies  >110 publications with VEGFR2 and Adenocarcinoma
 Neoplasms, Experimental Antibodies  >102 publications with VEGFR2 and Neoplasms, Experimental
 Breast Neoplasms Antibodies  >85 publications with VEGFR2 and Breast Neoplasms
 Inflammation Antibodies  >83 publications with VEGFR2 and Inflammation
 Drug Toxicity Antibodies  >81 publications with VEGFR2 and Drug Toxicity
 Atherosclerosis Antibodies  >73 publications with VEGFR2 and Atherosclerosis

Organs/Tissues associated with anti-VEGFR2 antibody

 Organ/Tissue Name  Pubmed Publications
 Vascular Antibodies  >1955 publications with VEGFR2 and Vascular
 Embryonic Tissue Antibodies  >239 publications with VEGFR2 and Embryonic Tissue
 Bone Antibodies  >231 publications with VEGFR2 and Bone
 Muscle Antibodies  >211 publications with VEGFR2 and Muscle
 Heart Antibodies  >174 publications with VEGFR2 and Heart
 Liver Antibodies  >165 publications with VEGFR2 and Liver
 Lung Antibodies  >161 publications with VEGFR2 and Lung
 Placenta Antibodies  >110 publications with VEGFR2 and Placenta
 Brain Antibodies  >98 publications with VEGFR2 and Brain
 Kidney Antibodies  >88 publications with VEGFR2 and Kidney